Forest Laboratories Inc. Class A (FRX1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
909 THIRD AVENUE, NEW YORK, NY 10022
(212)421-7850

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 26.829 Billion Shares Outstanding271 Million Avg 30-day Volume 2.868 Million
P/E Ratio152.349 Dividend Yield0.0 EPS0.61
Price to Revenue6.9058 Debt to Equity0.4866 EBITDA392.22 Million
Price to Book Value4.0848 Operating Margin3.0643 Enterprise Value24.862 Billion
Current Ratio2.73 EPS Growth6.083 Quick Ratio1.807
1 Yr BETA 1.123931 52-week High/Low 0.0 / Profit Margin4.5329
Operating Cash Flow Growth248.5227 Altman Z-Score4.2432 Free Cash Flow to Firm -2.895 Billion
View SEC Filings from FRX1 instead.

View recent insider trading info

Funds Holding FRX1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding FRX1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ICAHN CARL C

  • 10% Owner
No longer subject to file 2014-07-01 0

COUGHLIN CHRISTOPHER J

  • Director
No longer subject to file 2014-07-01 0

SALANS LESTER B

  • Director
No longer subject to file 2014-07-01 0

SOLOMON HOWARD

  • Director
No longer subject to file 2014-07-01 0

GOODMAN KENNETH E

  • Director
No longer subject to file 2014-07-01 0

OLANOFF LAWRENCE S

  • Director
No longer subject to file 2014-07-01 0

HOCHBERG ELAINE SEE REMARKS

  • Officer
No longer subject to file 2014-07-01 0

LIEBERMAN GERALD M

  • Director
No longer subject to file 2014-07-01 0

FRANCIS PERIER I JR EVP - CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2014-07-01 0

INTRIERI VINCENT J

  • Director
No longer subject to file 2014-07-01 0

BASGOZ NESLI

  • Director
No longer subject to file 2014-07-01 0

LEGAULT PIERRE

  • Director
No longer subject to file 2014-07-01 0

TAGLIETTI MARCO SEE REMARKS

  • Officer
No longer subject to file 2014-07-01 0

ZIMETBAUM PETER J.

  • Director
No longer subject to file 2014-07-01 0

WALSH KEVIN SVP - OPERATIONS

  • Officer
No longer subject to file 2014-07-01 0

ZIMMERMAN JOSEPH SVP - CHIEF COMPLIANCE OFFICER

  • Officer
No longer subject to file 2014-07-01 0

LYNCH JEROME SVP - SALES

  • Officer
No longer subject to file 2014-07-01 0

MEURY WILLIAM EVP - SALES AND MARKETING

  • Officer
No longer subject to file 2014-07-01 0

SAUNDERS BRENT L CEO & PRESIDENT

  • Officer
  • Director
No longer subject to file 2014-06-30 0

KELLY JOHN ALEXANDER SVP - CHIEF COMM'S & IR

  • Officer
No longer subject to file 2014-06-30 0

BAILEY A ROBERT D SVP CHIEF LEGAL OFF, GC & SEC

  • Officer
No longer subject to file 2014-06-30 0

LING KAREN SVP - CHIEF HR OFFICER

  • Officer
No longer subject to file 2014-06-30 0

PAULL SALLY SVP - HUMAN RESOURCES

  • Officer
25,185 2013-12-09 0

SOLOMON DAVID F SVP-CORPDEV/STRATEGIC PLANNING

  • Officer
166,858 2013-12-06 0

WEINSTEIN HERSCHEL S SVP GENERAL COUNSEL

  • Officer
103,509 2013-10-23 0

MURDOLO FRANK J VP - INVESTOR RELATIONS

  • Officer
33,343 2013-05-21 0

STAFFORD RAYMOND EVP GLOBAL MARKETING

  • Officer
188,940 2012-05-07 0

GOLDWASSER DAN L

  • Director
26,932 2011-08-23 0

CANDEE WILLIAM J III

  • Director
5,953 2010-12-16 0

COHAN GEORGE S

  • Director
48,658 2010-08-09 0

GERGEL IVAN SR VP - CHIEF SCI. OFFICER

  • Officer
15,000 2007-12-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments